These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6782611)

  • 21. The development of responsiveness to dopaminergic agonists.
    Reinstein DK; McClearn D; Isaacson RL
    Brain Res; 1978 Jul; 150(1):216-23. PubMed ID: 566610
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of piribedil on body temperature in mice and rats.
    Kapturkiewicz Z; Sowińska H
    Pol J Pharmacol Pharm; 1977; 29(6):609-18. PubMed ID: 600860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation of apomorphine from bromocriptine, piribidel and TRH by chronic administration in rats.
    Porreca F; Cowan A; Tallarida RJ
    Psychopharmacology (Berl); 1982; 76(1):70-4. PubMed ID: 6805012
    [No Abstract]   [Full Text] [Related]  

  • 24. Piribedil-induced anti-hypoxic protection in rats.
    Saligaut C; Moore N; Daoust M; Chretien P; Boismare F
    Aviat Space Environ Med; 1982 Jan; 53(1):35-9. PubMed ID: 7055488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of aripiprazole on alcohol intake in an animal model of high-alcohol drinking.
    Ingman K; Kupila J; Hyytiä P; Korpi ER
    Alcohol Alcohol; 2006; 41(4):391-8. PubMed ID: 16684847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerance and cross-tolerance to theophylline-induced stimulation of locomotor activity in rats.
    Finn IB; Holtzman SG
    Life Sci; 1988; 42(24):2475-82. PubMed ID: 3374267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute hypotensive effect of a central dopaminergic agonist, piribedil, administered intravenously in the normotensive human].
    Ziegler M; Georgiadis G; Elghozi JL
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1186-90. PubMed ID: 6441537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dopamine agonist piribedil with L-DOPA improves attentional dysfunction: relevance for Parkinson's disease.
    Turle-Lorenzo N; Maurin B; Puma C; Chezaubernard C; Morain P; Baunez C; Nieoullon A; Amalric M
    J Pharmacol Exp Ther; 2006 Nov; 319(2):914-23. PubMed ID: 16920993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of piribedil on nocturnal sleep (author's transl)].
    Passouant P; Besset A; Billiard M; Negre C
    Rev Electroencephalogr Neurophysiol Clin; 1978 Sep; 8(3):326-34. PubMed ID: 220684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective antagonism of the hypotensive effects of dopamine agonists in spontaneously hypertensive rats.
    McCoy CE; Douglas FL; Goldberg LI
    Hypertension; 1986 Apr; 8(4):298-302. PubMed ID: 2870024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockage of narcotic-induced dopamine receptor supersensitivity by cyclo(Leu-Gly).
    Ritzmann RF; Walter R; Bhargava HN; Flexner LB
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5997-8. PubMed ID: 293696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypodipsia, stereotypy and hyperactivity induced by beta-phenylethylamine in the water-deprived rat.
    Cooper SJ; Dourish CT
    Pharmacol Biochem Behav; 1984 Jan; 20(1):1-7. PubMed ID: 6538044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Responses of central neurones to piribedil and 2-bromo-alpha-ergocryptine: comparison with dopamine and apomorphine.
    Bioulac B; Fumoux F; Ferron A; Vincent JD
    Eur J Pharmacol; 1978 Sep; 51(1):29-37. PubMed ID: 699972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prejunctional actions of piribedil on the isolated kidney of the rabbit: comparison with apomorphine.
    Chevillard C; Mathieu MN; Recommis D
    Br J Pharmacol; 1980; 71(2):513-8. PubMed ID: 7470760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of dopamine in the locomotor stimulant effects and tolerance to these effects of caffeine.
    Powell KR; Iuvone PM; Holtzman SG
    Pharmacol Biochem Behav; 2001; 69(1-2):59-70. PubMed ID: 11420069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of a dopaminergic drug (piribedil) on pituitary hormone release in normal men and women.
    De Marinis L; Mancini A; Calabrò F; Massari M; Torlontano M; Barbarino A
    Acta Endocrinol (Copenh); 1983 Dec; 104(4):385-9. PubMed ID: 6419519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress.
    Papp M; Muscat R; Willner P
    Psychopharmacology (Berl); 1993; 110(1-2):152-8. PubMed ID: 7870876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
    Butterworth RF; Poignant JC; Barbeau A
    Adv Neurol; 1975; 9():307-26. PubMed ID: 1170716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Femoral vasodilatation produced by piribedil (ET495) and its metabolite S584 in the hindleg of the dog.
    Buylaert WA
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Aug; 299(1):101-3. PubMed ID: 904692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of apomorphine, piribedil and haloperidol on adrenal ornithine decarboxylase activity of the rat.
    Almazan G; Ramirez-Gonzalez MD; Sourkes TL
    Neuropharmacology; 1982 Jul; 21(7):631-7. PubMed ID: 6889689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.